Michel H. Klein
169Patents
19h-index
72Co-inventors
85Inventor score
Filing activity: Nov 23, 1988 → Jun 13, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6471996B1 | Biodegradable targetable microparticle delivery system | Emerging Cross-Sectional Technologies | 81 | Expired |
| US7018637B2 | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines | Emerging Cross-Sectional Technologies | 54 | Expired |
| US5085862A | Genetic detoxification of pertussis toxin | Emerging Cross-Sectional Technologies | 54 | Expired |
| US5681570A | Immunogenic conjugate molecules | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5679352A | Synthetic Haemophilus influenzae conjugate vaccine | Emerging Cross-Sectional Technologies | 45 | Expired |
| US5759769A | Tandem synthetic HIV-1 peptides | Emerging Cross-Sectional Technologies | 38 | Expired |
| US6080408A | Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles | Chemistry; Metallurgy | 32 | Expired |
| US5358868A | Genetic detoxification of pertussis toxin | Human Necessities | 31 | Expired |
| US6235523A | Vectors for DNA immunization against cervical cancer | Emerging Cross-Sectional Technologies | 28 | Expired |
| US6656472B1 | Multi oligosaccharide glycoconjugate bacterial meningitis vaccines | Emerging Cross-Sectional Technologies | 28 | Expired |
| US5506139A | Analog of haemophilus Hin47 with reduced protease activity | Chemistry; Metallurgy | 26 | Expired |
| US6019980A | Nucleic acid respiratory syncytial virus vaccines | Chemistry; Metallurgy | 26 | Expired |
| US6180398A | Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation | Chemistry; Metallurgy | 24 | Expired |
| US5439809A | Non-infectious HIV particles lacking long terminal repeats | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5843913A | Nucleic acid respiratory syncytial virus vaccines | Chemistry; Metallurgy | 21 | Expired |
| US5869302A | Analog of haemophilus hin47 with reduced protease activity | Chemistry; Metallurgy | 20 | Expired |
| US6225091A | Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory synctial virus | Physics | 20 | Expired |
| US5879925A | Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains | Physics | 20 | Expired |
| US5939297A | Analog of haemophilus HIN47 with reduced protease activity | Chemistry; Metallurgy | 19 | Expired |
| US5221618A | Genetic detoxification of pertussis toxin | Human Necessities | 19 | Expired |
| US5656436A | Analog of Haemophilus Hin47 with reduced protease activity | Chemistry; Metallurgy | 19 | Expired |
| US5876731A | Tandem synthetic HIV-1 Peptides | Emerging Cross-Sectional Technologies | 19 | Expired |
| US5935573A | Method of use of an analog of Haemophilus influenzae Hin47 with reduced protease activity | Chemistry; Metallurgy | 18 | Expired |
| US6025342A | Analog of Haemophilus Hin47 with reduced protease activity | Chemistry; Metallurgy | 18 | Expired |
| US5981503A | Analog of Haemophilus Hin47 with reduced protease activity | Chemistry; Metallurgy | 18 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.